Tim, thank you for the update. Are you sure it's time to buy LABD? Several people point out that XBI and IBB broke out of their channel and will continue to go higher.
Doge_1
⋅
XBI IBB will continue to uptrend until election focus is on biotech, there is a large misrepresentation of how these companies are valuing drugs. What is the need for a drug when the majority of the population is perfectly healthy? Some drugs are only target less than 1% of the global population so how does that justify making drug companies reach billions of valuation?